WILEX AG - Research and development of smallmolecule drugs for autoimmune diseases and cancer video

Bit Index AI |

Broadcast Live | Upload & Publish |

About |

Close [ x ]

Forgotten Password?

You need to install or upgrade your Flash Player!

3B NEXUS video platform & portal supports the latest version of Macromedia Flash player.

3B PLAYER by 3B NEXUS

Close [ X ]

Copy this code to embed & stream this video on your website

<div id="svp_player1120715" style="width:636px;height:342px;"><strong>You need to install or upgrade your Flash Player!</strong><br><a href="http://www.macromedia.com/go/getflashplayer" target="_new"><img src="../../img/flash_link.gif" border="0" width="88" height="31"/></a>
	<p>3B NEXUS video platform & portal supports the latest version of  <a href="http://www.macromedia.com/go/getflashplayer" target="_new">Macromedia Flash</a> player.</p> 
	<hr/> <center><h3>3B PLAYER by <a href="/">3B NEXUS</a></center></div>
	<script language="JavaScript">
svp_clip_id = "1120715";
nexus_user_id = "";
svp_player_color1 = "#3399FF";
svp_player_color = "#010101";
svp_player_color_ratio = 1.0;
svp_player_height = "342";
svp_player_width = "636";
svp_transparent = "true";
svp_pause="1";
svp_stretch_video=1;
svp_start_volume="15";
svp_bg_color="#FFFFFF";
svp_fs_mode="2";
svp_no_fullscreen="0";
svp_no_controls="";
svp_auto_hide="1";
svp_skin="2";
svp_start_img="0";
svp_use_div="svp_player1120715";
</script>
<script language="JavaScript" type="text/javascript" src="../../js/eplayer.js"></script>

Copy this URL to share or create a link back to this video

WILEX AG (WL6)

Prof. Dr. Olaf G. Wilhelm

Chief Executive Officer

Germany

WILEX AG - Research and development of smallmolecule drugs for autoimmune diseases and cancer

The therapeutic agent RENCAREX® (INN: Girentuximab) is a targeted antibody for the treatment of solid tumours. The antibody Girentuximab binds to the CA IX antigen expressed on the tumour cells, thereby triggering an immune reaction called Antibody-Dependent Cellular Cytotoxicity (ADCC). Through this mechanism, effector cells, e.g. NK (natural killer) cells, of the immune system are activated to kill the tumour cells.

Visit Website Disclaimer View Channel Factsheet Presentation Press Release

Please select a Media Channel	[ close ]
Please select the appropriate option to comply with legal regulations

Individual Investor

Professional Investor or Financial Advisor

This multimedia channel includes videos, webcasts and live broadcasts suitable for members of the general public over 18 years of age and not engaged in providing investment advice. Access this channel for personal interest & information only.

This multimedia channel includes investor videos and webcast presentations, live broadcasts and documents intended only for authorised and regulated professionals and financial advisers eligible to provide investment advice to private investors.

* I comply with these terms

Remember my choice for all channels on this portal

Enter Media Channel »

No reliance should be placed on the information on this site which may change without notice.

You should read the Terms & Conditions section before browsing this site.